The Role of Checkpoint inhibitors in CIA
The Role of Checkpoint inhibitors in CIA
批准号:
10319910
负责人:
Megan Kay Wood
金额:
$4.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2023-06-30
关键词:
AffectArthritisAutoimmune DiseasesBone MarrowCD3 AntigensCD8-Positive T-LymphocytesCD8B1 geneCSF1R geneCTLA4 geneCellsCessation of lifeChimera organismCollagen ArthritisDataDiseaseFemurFrequenciesHarvestHomeostasisHumanImmuneImmune checkpoint inhibitorInflammationInflammatory ArthritisJointsKnee jointKnockout MiceLinkMusMyeloid CellsOperative Surgical ProceduresPTPRC geneParabiosisPathogenesisPathway interactionsPatientsPeripheralPhenotypePlayPopulationRecoveryRegulationRheumatoid ArthritisRoleSeveritiesSynovial FluidSynovitisSystemT memory cellT-LymphocyteTechniquesTestingTherapeuticTissuesanti-CTLA4anti-PD-1anti-PD-L1cell stromadisabilityexperimental studyimmune checkpointimmune-related adverse eventsinhibitor/antagonistjoint inflammationmacrophagemouse modelnovelprematureprogrammed cell death ligand 1programmed cell death protein 1tibia
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Immune related adverse events linked to severe inflammatory arthritis have been identified in 10-43% of patients
receiving immune checkpoint inhibitors, αCTLA4, αPD-1 or αPD-L1, indicating the importance of immune
inhibitory pathways in maintaining homeostasis in the joints. We obtained human synovial fluid and found a high
frequency of PD-L1 expression by synovial macrophages. We propose to examine the role of PD-L1 expression
in synovial macrophages and T cells during murine collagen induced arthritis (CIA). We found that immune
checkpoint inhibitor, PD-L1, is primarily expressed in the joint compared to other immune checkpoints.
Additionally, we found synovial macrophages and CD3+ T cells are the main PD-L1 expressing cells in the joint,
and PD-L1 expression is increased during CIA. We extensively profiled the synovial macrophages and found
three populations of PD-L1 expressing cells: F4/80intCD115+CCR2-MHCII-CD73-Tim4-PD-L1hi (CD115+
macrophages), F4/80hiCD115-CCR2intMHCIIhiCD73intTim4intPD-L1int (MHCII+ macrophages), and F4/80intCD115-
CCR2lowMHCII-CD73loTim4intPD-L1int (F4/80+ macrophages). We have also found that PD-L1 has the highest
frequency of expression in CD4+ and CD8+ T cells. Furthermore, we identified a novel subset of joint tissue
resident memory T cells in the naïve joint that are phenotypically CD8+CD69+ and CD8+CD69+CD103+. We
hypothesize that the expression of PD-L1 by macrophages and/or T cells are essential for synovial
homeostasis and regulation of joint inflammation. In Aim 1, we will examine the importance of PD-L1
expression by synovial macrophages through the selective deletion of PD-L1 using the cre/flox system. We will
generate two macrophages specific PD-L1 KO mice, LyzcrePD-L1fl/fl and CD115crePD-L1fl/fl. We will induce CIA in
LyzcrePD-L1fl/fl, CD115crePD-L1fl/fl, Lyzcre and CD115cre mice and harvest the joint to determine the protective role
of synovial macrophage PD-L1 expression in CIA (Subaim 1.1). We will also perform parabiosis experiments by
surgically joining CD45.1 C57BL6 and CD45.2 CD115crePD-L1fl/fl to determine if PD-L1+ synovial macrophages
are resident or bone marrow derived during CIA (Subaim 1.2). We have found that PD-L1 is highly expressed
in synovial T cells. In Aim 2, we will examine the protective function of synovial T cells following CIA. We will use
LckcreP D-L1fl/fl mice, which lack PD-L1 expression in CD3+ T cells to examine the effects of PD-L1 specific
deletion in T cells during CIA (Subaim 2.1). To test if tissue resident memory T cells play a protective role during
CIA, we will utilize a tissue resident chimera mouse model to selectively delete peripheral T cells in LckcrePD-
L1fl/fl mice. Donor T cells from LckcrePD-L1fl/fl or Lckcre mice will replace peripheral T cell populations to confirm
the protective function of tissue resident memory T cells in the joint (Subaim 2.2). Our project has high
translational potential since joint specific PD-L1 expression could be modulated with therapeutic purposes in
humans for rheumatoid arthritis or check point inhibitors induced arthritis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Checkpoint inhibitors in CIA
-
批准号:10437927
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2020
-
负责人:Megan Kay Wood
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位:
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: